Recombinant Human SFTA3 Protein，His

SFTA3, or Surfactant Protein A3, is a member of the surfactant protein family, which plays a crucial role in pulmonary surfactant function and innate immunity in the lungs. Research into SFTA3 has gained momentum due to its potential implications in respiratory diseases, including pulmonary fibrosis, asthma, and various infections. The protein is expressed in the alveolar epithelium and is pivotal for maintaining alveolar stability, host defense, and inflammatory responses. Understanding the structure and function of SFTA3 at the molecular level is essential for elucidating its role in lung physiology and pathophysiology. Recent studies have focused on the recombinant expression of SFTA3 to facilitate detailed functional analyses and explore its potential as a therapeutic target. By using techniques such as molecular cloning and expression in heterologous systems, researchers aim to produce SFTA3 in sufficient quantities for biochemical and biophysical characterization. Additionally, investigations into the binding properties of SFTA3 with pathogens, lipids, and other proteins enhance our knowledge of its multi-faceted roles in the lung environment. Overall, the research on SFTA3 not only contributes to our understanding of respiratory biology but also opens avenues for developing novel strategies for treating lung diseases.